Chua T, Punjabi L, Khor L
Pathogens. 2021; 10(11).
PMID: 34832566
PMC: 8624235.
DOI: 10.3390/pathogens10111410.
Lo M, Zhu J, Hansen S, Carroll T, Farr Zuend C, Noel-Romas L
J Virol. 2018; 93(2).
PMID: 30333177
PMC: 6321901.
DOI: 10.1128/JVI.01574-18.
Efird J, Toland A, Suzanne Lea C, Phillips C
Clin Med Insights Oncol. 2011; 5:55-75.
PMID: 21499554
PMC: 3076039.
DOI: 10.4137/CMO.S6905.
Tummon I, Dudley D, Walters J
Can Med Assoc J. 1981; 125(1):23-9.
PMID: 7020907
PMC: 1862593.
Ingoldby C, McWhinney N, Wachtel E, Castro J
J Clin Pathol. 1980; 33(10):990-2.
PMID: 7000832
PMC: 1146300.
DOI: 10.1136/jcp.33.10.990.
Early and late pathologic changes in the adrenal glands of mice after infection with herpes simplex virus type 1.
Nachtigal M, CAULFIELD J
Am J Pathol. 1984; 115(2):175-85.
PMID: 6372493
PMC: 1900495.
Detection of herpes simplex virus type-2 DNA restriction fragments in human cervical carcinoma tissue.
Park M, Kitchener H, Macnab J
EMBO J. 1983; 2(7):1029-34.
PMID: 6313349
PMC: 555230.
DOI: 10.1002/j.1460-2075.1983.tb01541.x.
Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.
Skinner G, Buchan A, Williams D, Marsden J, Hartley C, Wilbanks G
Br J Exp Pathol. 1982; 63(4):378-87.
PMID: 6295430
PMC: 2040654.
Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
Skinner G, Woodman C, Hartley C, Buchan A, Fuller A, Durham J
Br J Vener Dis. 1982; 58(6):381-6.
PMID: 6293640
PMC: 1046107.
DOI: 10.1136/sti.58.6.381.
The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.
Skinner G, Buchan A, Hartley C, Turner S, Williams D
Med Microbiol Immunol. 1980; 169(1):39-51.
PMID: 6258035
DOI: 10.1007/BF02123711.
Herpes simplex virus infection: problems and prospects as perceived by a peripatetic pediatrician.
Nahmias A
Yale J Biol Med. 1980; 53(1):47-54.
PMID: 6246686
PMC: 2595848.
Genital herpes and cervical cancer.
Br Med J. 1970; 4(5730):256-7.
PMID: 5475842
PMC: 1819830.
Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine.
SLOAN B, Miller F, McLEAN Jr I
Antimicrob Agents Chemother. 1973; 3(1):74-80.
PMID: 4790577
PMC: 444363.
DOI: 10.1128/AAC.3.1.74.
Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus.
Cooper G
Proc Natl Acad Sci U S A. 1973; 70(12):3788-92.
PMID: 4359489
PMC: 427329.
DOI: 10.1073/pnas.70.12.3788.
Characterization of genital strains of Herpesvirus hominis.
Smith I, Peutherer J, Robertson D
Br J Vener Dis. 1973; 49(4):385-90.
PMID: 4353618
PMC: 1044936.
DOI: 10.1136/sti.49.4.385.
A DNA fragment of Herpes simplex 2 and its transcription in human cervical cancer tissue.
Frenkel N, Roizman B, Cassai E, Nahmias A
Proc Natl Acad Sci U S A. 1972; 69(12):3784-9.
PMID: 4345508
PMC: 389873.
DOI: 10.1073/pnas.69.12.3784.
Herpes genitalis.
Br Med J. 1972; 1(5795):264-5.
PMID: 4332778
PMC: 1787202.
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease.
Nahmias A, Dowdle W, NAIB Z, Josey W, McLone D, Domescik G
Br J Vener Dis. 1969; 45(4):294-8.
PMID: 4311650
PMC: 1047996.
DOI: 10.1136/sti.45.4.294.
Herpes simplex cervicitis.
Hutchfield D
Br Med J. 1968; 2(5604):560.
PMID: 4302078
PMC: 1991845.
DOI: 10.1136/bmj.2.5604.560.
Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2.
Duff R, Rapp F
J Virol. 1971; 8(4):469-77.
PMID: 4108570
PMC: 376220.
DOI: 10.1128/JVI.8.4.469-477.1971.
